Non-Hodgkin’s Lymphomas and AIDS

Authors

  • Marisa Silva Médica do Internato Complementar de Medicina Interna, Serviço de Medicina 2 do Hospital São Bernardo, Setúbal (Estágio de Hematologia no Serviço de Hematologia Clínica do Hospital Santo António dos Capuchos).

Keywords:

Non-Hodgkin’s lymphoma, AIDS

Abstract

Non-Hodgkin’s lymphoma occurs among all population groups at risk for HIV infection, in
all age groups and in different countries, with similar epidemiologic and clinico-pathologic
features. Clinical presentations may include systemic lymphoma, primary CNS lymphoma,
and primary effusion lymphoma. Recent investigations have led to the identification of a
particular type of AIDS-related non-Hodgkin’s lymphoma defined as plasmablastic lymphoma
of the oral cavity.
Systemic AIDS-NHL are a heterogeneous group of malignancies displaying a B-cell phenotype, and at the time of diagnosis approximately 75% of patients have advanced diseasemwith frequent involvement of extra-nodal sites,
the most common being the CNS, bone marrow, gastrointestinal tract and liver.
Regarding patients followed in the Santo António dos Capuchos Hospital, the authors made a retrospective analysis of systemic AIDS-NHL cases admitted to a Department of Haematology over a six year period. The following parameters were assessed: sex, age, performance status, AIDS-defining conditions prior to the diagnosis, opportunistic infection, CD4 cell
count, histology, involvement of the bone marrow and CNS, treatment and evolution.

Downloads

Download data is not yet available.

References

Kersten MJ, Van Oers RHJ. Management of AIDS-Related Non-Hodgkin´s Lymphomas. Drugs 2001:61(9); 1301-1315

Levine AM, Seneviratne L, Espina BM et al. Evolving characteristics of AIDS-related lymphoma. Blood 2000:96

Carbone A, Gloghini A, Capello D, Gaidano G. Genetic pathways and histogenetic models of AIDS-related lymphomas. Eur J Cancer

:37;1270-1275.

Knowles DM, Pirog EC. Pathology of AIDS-related lymfhomas and other AIDS-defining neoplasms. Eur J Cancer 2001 :37 ; 1236-1250.

Dolcetti R, Boiocchi M, Gloghini A, Carbone A. Pathogenetic and histogenetic features of HIV-Associated Hodgkin`s disease. Eur J

Cancer 2001:37 ;1276-1287.

Bower M. Acquired Immunodeficiency Syndrome-related systemic Non-Hodgkin´s lymphoma. Br J Haematology 2001:112 ; 863-873.

Spina M, Vaccher E, Carbone A, Tirelli U. Neoplastic complications of HIV infection. Ann Oncol 1999:10;1271-1286.

Levine Am. Epidemiology, clinical characteristics and management of AIDS related Lymphoma. Haematol. Oncol Clin of North Am 1991: 5 (2); 331-342.

Levine AM. AIDS associated malignant lymphoma. Med Clin of North Am 1992: 76 (1); 253-280.

Levine AM. Lymphoma in AIDS. Sem In Oncol 1990: 17 (1); 104-112.

Levine AM. AIDS related lymphoma. Blood 1992: 80;8-20.

Mitsuyasu R. Oncological Complications of Human Immunodeficiency Virus Disease and Hematologic Consequences of their Treatment. Clin Inf Dis 1999: 29 ; 35-43.

Ratner L, Lee J, Tang S et al. Chemotherapy for Human Immunodeficiency Virus-Associated Non- Hodgkin´s Lymphoma in Combination

with Highly Active Antiretroviral Therapy. J Clin Oncol 2001:19 (8); 2171-2178.

Spina M, Vaccher E, Juzbasic S et al. Human Immunodeficiency Virus-related Non-Hodgkin Lymphoma. Activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients. Cancer 2001:92;200-206

Sparano JA. Clinical aspects and management of AIDS-related lymphoma. Eur J Cancer 2001:37 ;1296-1305.

Navarro JT, Ribera JM, Oriol A et al. Influence of highly active anti-retroviral therapy on response to treatment and survival in patients

with acquired immunodeficiency syndrome-related non-Hodgkin´s lymphoma treated with cyclophosphamide, hydroxydoxorubicin,

vincristine and prednisone. Br J Haemat 2001:112;909-915.

Grulich AE, Li Y, McDonald AM et al. Decreasing rates of Kaposi´s sarcoma and non-Hodgkin´s lynphoma in the era of potent combination

anti-retroviral therapy. AIDS 2001:15; 629-633.

Rabkin CS. AIDS and cancer in the era of highly active antiretroviral therapy. Eur J Cancer 2001:37 ;1316-1319.

Tirelli U, Bernardi D. Impact of HAART on the clinical management of AIDS-related cancers. Eur J Cancer 2001:37 ;1320-1324.

Besson C, Goubar A, Gabarre J et al. Changes in AIDS-related Lymphoma since the era of highly active antiretroviral therapy. Blood

:98;2339-2344

Antinori A, Cingolani A, Alba L et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to

highly active antiretroviral therapy. AIDS 2001:15;1483-1491.

Additional Files

Published

2003-12-31

How to Cite

1.
Silva M. Non-Hodgkin’s Lymphomas and AIDS. RPMI [Internet]. 2003 Dec. 31 [cited 2024 Nov. 21];10(4):179-84. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1826

Issue

Section

Original Articles

Most read articles by the same author(s)